SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-22-000016
Filing Date
2022-02-03
Accepted
2022-02-03 07:08:37
Documents
15
Period of Report
2022-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lly-20220203.htm   iXBRL 8-K 74095
2 EX-99.1 q421lillysalesandearningsp.htm EX-99.1 477172
7 logoa31.jpg GRAPHIC 14287
  Complete submission text file 0000059478-22-000016.txt   871426

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20220203.xsd EX-101.SCH 4836
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20220203_def.xml EX-101.DEF 20251
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20220203_lab.xml EX-101.LAB 43671
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20220203_pre.xml EX-101.PRE 21479
9 EXTRACTED XBRL INSTANCE DOCUMENT lly-20220203_htm.xml XML 33270
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 22586528
SIC: 2834 Pharmaceutical Preparations